SCHEMBL3846705

SCHEMBL3846705

NNC(=O)c1ncnc2ccc(Br)cc12

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 5/20 0.51
MAPT P10636 3/20 0.51
ALDH1A1 P00352 7/20 0.51
KDM4E B2RXH2 3/20 0.51
GAA P10253 3/20 0.51
RXFP1 Q9HBX9 2/20 0.48
HTT P42858 6/20 0.48
CCNC P24863 1/20 0.48
CDK8 P49336 1/20 0.48
POLB P06746 1/20 0.47
ALK Q9UM73 1/20 0.47
HPGD P15428 1/20 0.47
MTOR P42345 1/20 0.47
NCOA1 Q15788 1/20 0.47
NCOA3 Q9Y6Q9 1/20 0.47
SMN1; SMN2 Q16637 2/20 0.47
P4HB P07237 1/20 0.46
EGFR P00533 1/20 0.45
PRNP P04156 1/20 0.44
TSHR P16473 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21756436 0.81 KDM4E (0.53) LMNAMAPTALDH1A1KDM4ERXFP1
Ammonia Solution, Strong SCHEMBL3853118 0.80 KDM4E (0.52) LMNAMAPTALDH1A1KDM4ERXFP1
SCHEMBL3845935 0.79 HTT (0.56) LMNAMAPTALDH1A1KDM4ERXFP1
SCHEMBL3845613 0.77 IRAK4 (0.43) LMNAMAPTALDH1A1KDM4ERXFP1
SCHEMBL7660019 0.76 ALDH1A1 (0.62) LMNAMAPTALDH1A1KDM4EGAA
SCHEMBL4354970 0.74 HTT (0.63) LMNAMAPTALDH1A1KDM4EHTT
SCHEMBL26178685 0.73 HTT (0.52) ALDH1A1KDM4EHTTPOLBHPGD
SCHEMBL22518521 0.73 ALDH1A1 (0.45) LMNAMAPTALDH1A1KDM4EGAA
SCHEMBL13621687 0.72 RXFP1 (0.70) LMNAMAPTALDH1A1KDM4ERXFP1
SCHEMBL23234945 0.71 GAA (0.55) LMNAMAPTALDH1A1KDM4EGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2048142-A2 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof Eisai R&D Management Co., Ltd. (JP) 2009-04-15 EP disclosed
EP-1382603-B1 NITROGENOUS FUSED-RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF EISAI R&D MAN CO LTD (JP) 2008-07-23 EP disclosed
US-7074801-B1 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof EISAI CO., LTD. (JP) 2006-07-11 US disclosed
EP-1382603-A1 NITROGENOUS FUSED−RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF Eisai Co., Ltd. (JP) 2004-01-21 EP disclosed